Skip to main content
رجوع
BEAM logo

Beam Therapeutics Inc.

جودة البيانات: 100%
BEAM
NASDAQ Healthcare Biotechnology
KWD 23.95
▼ KWD 1.22 (-4.85%)
القيمة السوقية: 2.44B
نطاق اليوم
KWD 23.62 KWD 24.73
نطاق 52 أسبوعًا
KWD 13.53 KWD 36.44
حجم التداول
1,584,045
متوسط 50 يوم / 200 يوم
KWD 28.35 / KWD 23.72
الإغلاق السابق
KWD 25.17

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (627 نظير)

المقياس السهم وسيط القطاع
P/E -30.5 0.3
P/B 2.0 2.9
ROE % -8.1 3.7
Net Margin % -57.2 3.8
Rev Growth 5Y % 28.1 10.0
D/E 0.2 0.2

السعر المستهدف للمحللين

Hold
KWD 40.860 +70.6%
Low: KWD 26.000 High: KWD 74.000
ربحية السهم المستقبلية
-KWD 4.364
الإيرادات المقدّرة
45 M

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 -KWD 1.267
-KWD 2.984 – -KWD 0.268
710 M 4
FY2029 -KWD 3.229
-KWD 7.605 – -KWD 0.682
410 M 4
FY2028 -KWD 4.648
-KWD 7.931 – -KWD 2.939
140 M 10

النقاط الرئيسية

Revenue grew 28.13% annually over 5 years — strong growth
Debt/Equity of 0.24 — conservative balance sheet
Negative free cash flow of -360.05M
PEG of 0.42 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 91.88%

النمو

Revenue Growth (5Y)
28.13%
Revenue (1Y)120.01%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-8.11%
ROIC-18.78%
Net Margin-57.24%
Op. Margin-274.57%

الأمان

Debt / Equity
0.24
Current Ratio13.09
Interest Coverage-8.77

التقييم

P/E Ratio
-30.50
P/B Ratio1.97
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 120.01% Revenue Growth (3Y) -39.17%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 28.13% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 139.74M Net Income (TTM) -79.99M
ROE -8.11% ROA -5.40%
Gross Margin 84.05% Operating Margin -274.57%
Net Margin -57.24% Free Cash Flow (TTM) -360.05M
ROIC -18.78% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.24 Current Ratio 13.09
Interest Coverage -8.77 Dividend Yield 0.00%
Valuation
P/E Ratio -30.50 P/B Ratio 1.97
P/S Ratio 17.46 PEG Ratio 0.42
EV/EBITDA N/A Dividend Yield 0.00%
Market Cap 2.44B Enterprise Value 2.44B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 139.74M 63.52M 377.71M 60.92M 51.84M
Net Income -79.99M -376.74M -132.53M -289.09M -370.64M
EPS (Diluted) -0.81 -4.58 -1.72 -4.13 -5.77
Gross Profit 117.45M -304.04M 377.71M -250.67M -180.29M
Operating Income -383.69M -415.57M -176.49M -338.48M -392.47M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 1.48B 1.10B 1.46B 1.34B 1.47B
Total Liabilities 242.82M 370.28M 478.39M 608.24M 647.72M
Shareholders' Equity 1.24B 733.55M 981.33M 733.47M 826.74M
Total Debt 293.88M 161.43M 172.69M 179.01M 147.64M
Cash & Equivalents 294.94M 281.97M 435.90M 232.77M 559.99M
Current Assets 1.27B 878.15M 1.21B 1.09B 1.27B
Current Liabilities 96.94M 182.07M 205.57M 223.60M 213.44M

درجات الاستراتيجيات

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Custom Full Throttle
#34 of 146
60

النشاط الأخير

دخل Full Throttle
Mar 24, 2026